Sarah Able

731 total citations
22 papers, 585 citations indexed

About

Sarah Able is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah Able has authored 22 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah Able's work include Radiopharmaceutical Chemistry and Applications (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and RNA Interference and Gene Delivery (3 papers). Sarah Able is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and RNA Interference and Gene Delivery (3 papers). Sarah Able collaborates with scholars based in United Kingdom, United States and France. Sarah Able's co-authors include Katherine A. Vallis, Ole Tietz, R. Chalk, Fernando Cortezon‐Tamarit, Carolyn Napier, Bart Cornelissen, Veerle Kersemans, Sidath Katugampola, Siân E. Harding and William B. Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Cancer Research.

In The Last Decade

Sarah Able

22 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Able United Kingdom	14	265	166	118	109	77	22	585
Benoît Thezé France	17	306 1.2×	150 0.9×	234 2.0×	92 0.8×	114 1.5×	25	948
Lorena Cussó Spain	13	343 1.3×	128 0.8×	60 0.5×	63 0.6×	112 1.5×	35	901
Rebecca E. Jimenez United States	9	531 2.0×	147 0.9×	35 0.3×	61 0.6×	123 1.6×	13	1.0k
T. Murray United Kingdom	10	338 1.3×	209 1.3×	100 0.8×	360 3.3×	177 2.3×	21	913
Stephen H. Cody Australia	16	480 1.8×	74 0.4×	38 0.3×	121 1.1×	51 0.7×	27	951
Sandra Plaza‐García Spain	13	140 0.5×	198 1.2×	56 0.5×	131 1.2×	20 0.3×	24	537
Choi‐Fong Cho United States	13	422 1.6×	239 1.4×	44 0.4×	104 1.0×	130 1.7×	20	811
Yuka Morita Japan	13	263 1.0×	86 0.5×	25 0.2×	53 0.5×	32 0.4×	40	638
Ildikó Horváth Hungary	15	178 0.7×	188 1.1×	162 1.4×	116 1.1×	37 0.5×	37	625

Countries citing papers authored by Sarah Able

Since Specialization

Citations

This map shows the geographic impact of Sarah Able's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Able with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Able more than expected).

Fields of papers citing papers by Sarah Able

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Able. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Able. The network helps show where Sarah Able may publish in the future.

Co-authorship network of co-authors of Sarah Able

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Able. A scholar is included among the top collaborators of Sarah Able based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Able. Sarah Able is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dias, Gemma, et al.. (2023). Abstract 5038: Evaluation of anti-tumor immunity in response to [177Lu]Lu-PSMA in a mouse model of prostate cancer. Cancer Research. 83(7_Supplement). 5038–5038. 1 indexed citations

Tietz, Ole, Fernando Cortezon‐Tamarit, R. Chalk, Sarah Able, & Katherine A. Vallis. (2022). Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells. Nature Chemistry. 14(3). 284–293. 110 indexed citations

Owen, Joshua, Keiran Logan, Heather Nesbitt, et al.. (2021). Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy. SHILAP Revista de lepidopterología. 3(2). 394–401. 20 indexed citations

Browning, Richard J., Sarah Able, Jia-Ling Ruan, et al.. (2021). Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer. Journal of Controlled Release. 337. 371–377. 32 indexed citations

Hauton, David, John Walsby-Tickle, Eloïse Thomas, et al.. (2021). 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation. SHILAP Revista de lepidopterología. 9(1). 37–37. 14 indexed citations

Song, Lei, Mark R. Jackson, Sarah Able, et al.. (2021). Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides. Molecular Pharmaceutics. 18(10). 3820–3831. 18 indexed citations

Gill, Martin R., Michael G. Walker, Sarah Able, et al.. (2020). An ¹¹¹In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells. Chemical Science. 11(33). 8936–8944. 13 indexed citations

Lee, B. Q., Sarah Able, James Thompson, et al.. (2019). Radiosensitivity of colorectal cancer to ⁹⁰Y and the radiobiological implications for radioembolisation therapy. Physics in Medicine and Biology. 64(13). 135018–135018. 13 indexed citations

Gill, Martin R., Jyothi U. Menon, Paul J. Jarman, et al.. (2018). ¹¹¹In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells. Nanoscale. 10(22). 10596–10608. 62 indexed citations

10.

Falzone, Nadia, B. Q. Lee, Sarah Able, et al.. (2018). Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability. Journal of Nuclear Medicine. 60(2). 250–258. 26 indexed citations

11.

Song, Lei, Sarah Able, Errin Johnson, & Katherine A. Vallis. (2017). Accumulation of ¹¹¹In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand. Nanotheranostics. 1(3). 232–243. 18 indexed citations

12.

Corroyer‐Dulmont, Aurélien, Nadia Falzone, Veerle Kersemans, et al.. (2017). Improved outcome of 131 I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma. Radiotherapy and Oncology. 124(3). 488–495. 11 indexed citations

13.

Cornelissen, Bart, Sarah Able, Christiana Kartsonaki, et al.. (2014). Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer. Journal of Nuclear Medicine. 55(12). 2026–2031. 12 indexed citations

14.

Cornelissen, Bart, Andrew M. Waller, Sarah Able, & Katherine A. Vallis. (2013). Molecular Radiotherapy Using Cleavable Radioimmunoconjugates That Target EGFR and γH2AX. Molecular Cancer Therapeutics. 12(11). 2472–2482. 19 indexed citations

15.

Cornelissen, Bart, Sarah Able, & Katherine A. Vallis. (2013). Targeting {gamma}H2AX during oncogenesis with Auger electron therapy delays tumor onset. 54. 121. 1 indexed citations

16.

Johnson, William B., Sidath Katugampola, Sarah Able, Carolyn Napier, & Siân E. Harding. (2012). Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: Comparison with rat and guinea pig. Life Sciences. 90(9-10). 328–336. 63 indexed citations

17.

Cornelissen, Bart, Sarah Able, Veerle Kersemans, et al.. (2012). Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials. 34(4). 1146–1154. 67 indexed citations

18.

Able, Sarah, et al.. (2010). Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat. British Journal of Pharmacology. 162(2). 405–414. 43 indexed citations

19.

Able, Sarah, et al.. (2009). Localisation of melanin-concentrating hormone receptor 1 in rat brain and evidence that sleep parameters are not altered despite high central receptor occupancy. European Journal of Pharmacology. 616(1-3). 101–106. 10 indexed citations

20.

Able, Sarah, Paul Griffin, Ian James, et al.. (2009). Chapter 2 CCR5 Pharmacology Methodologies and Associated Applications. Methods in enzymology on CD-ROM/Methods in enzymology. 460. 17–55. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact